Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wellnex LifeASX:WNX Equity-to-Asset is 0.36 as of Dec. 2025, which is 5% below its 10-year median of 0.38. The stock has 2 warning signs investors should review. Among 2,001 Consumer Packaged Goods companies, Wellnex Life ranks worse than 76.31% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Wellnex Life's Total Stockholders Equity for the quarter that ended in Dec. 2025 was A$10.04 Mil. Wellnex Life's Total Assets for the quarter that ended in Dec. 2025 was A$27.83 Mil.
Therefore, Wellnex Life's Equity to Asset Ratio for the quarter that ended in Dec. 2025 was 0.36.
The historical rank and industry rank for Wellnex Life's Equity-to-Asset or its related term are showing as below:
ASX:WNX'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.02 Med: 0.38 Max: 0.95
Current: 0.36
During the past 9 years, the highest Equity to Asset Ratio of Wellnex Life was 0.95. The lowest was -0.02. And the median was 0.38.
ASX:WNX's Equity-to-Asset is ranked worse than 76.31% of 2001
companies
in the Consumer Packaged Goods industry
Industry Median: 0.55
vs ASX:WNX: 0.36
Wellnex Life (ASX:WNX) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Wellnex Life Equity-to-Asset Related Terms
Wellnex Life Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Wellnex Life's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Wellnex Life's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wellnex Life Equity-to-Asset vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Wellnex Life's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Wellnex Life's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Wellnex Life's Equity to Asset Ratio for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wellnex Life (ASX:WNX) has a Equity-to-Asset of 0.36 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Wellnex Life and its competitors. This is near median its historical median of 0.38. According to the industry distribution chart, Wellnex Life ranks #1527 out of 2001 companies in the Consumer Packaged Goods industry, placing it in the top 76.3%.
Is Wellnex Life's Equity-to-Asset too high?
Wellnex Life's current Equity-to-Asset of 0.36 is near median its 10-year median of 0.38. The Consumer Packaged Goods industry median Equity-to-Asset is 0.55. Wellnex Life's value of 0.36 is 34.5% below this industry median. Based on the distribution chart, Wellnex Life ranks #1527 out of 2001 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does Wellnex Life's Equity-to-Asset compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Wellnex Life ranks #1527 out of 2001 companies for Equity-to-Asset. This places Wellnex Life in the lower half of its industry. The industry median Equity-to-Asset is 0.55. Wellnex Life's value of 0.36 is 34.5% below this benchmark. While the company's 10-year median is 0.38 vs. the industry median of 0.55, Wellnex Life has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Consumer Packaged Goods company?
The median Equity-to-Asset among Consumer Packaged Goods companies is 0.55, based on 2,001 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wellnex Life's current Equity-to-Asset of 0.36 is 34.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Wellnex Life and its competitors. For the Consumer Packaged Goods industry, the median Equity-to-Asset is 0.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wellnex Life's current Equity-to-Asset is 0.36, which is near median its own 10-year median of 0.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wellnex Life stock overvalued right now?
Based on GuruFocus' analysis, Wellnex Life (ASX:WNX) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.35, compared to a current price of A$0.06 — trading 84.3% below its estimated fair value. The current Equity-to-Asset is 0.36, which is near median its 10-year median of 0.38 and 34.5% below the Consumer Packaged Goods industry median of 0.55. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Wellnex Life (ASX:WNX), the current Equity-to-Asset is 0.36 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Wellnex Life Ltd is a consumer healthcare company focused on developing, licensing, marketing, and distributing healthcare and pharmaceutical products. These products are available mainly through Australian retailers and wholesalers, including Coles, Woolworths, Chemist Warehouse, Sigma, and Symbion. The group's offerings include caffeine energy liquid capsules, multivitamins, pain relief creams and sprays, sleep aids, toothpaste, over-the-counter medicines, and medical cannabis products, among others. Its brands include Pharmacy Own, Wellness Life, Mr. Bright, Pain Away, Nighty Night, Wakey Wakey, and Wagner Health Liquigesic. Geographically, the majority of the group's revenue comes from Australia, with additional contributions from the United Kingdom and New Zealand.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:WNX has been successfully added to your 
